Bionano Genomics Company
BioNano Genomics develops nanoscale imaging and analytic platforms designed to analyze DNA and other genome-related peptides and proteins.
Investor Type:
N/A
Technology:
Сancer Diagnostics
Investment Stage:
N/A
Estimated Revenue:
$1M to $10M
Founded Date:
01.01.2003
Industry:
Deep Diagnostics
Employee Number:
11-50
Funding Status:
IPO
Number Of Exists:
N/A
Headquarters:
San Diego, California, United States